100
Participants
Start Date
November 4, 2022
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2027
Cenobamate
Cenobamate will be orally administered once daily.
RECRUITING
Ehime University Hospital, Ehime
RECRUITING
Department of Neurology and Stroke Center, Southern Tohoku Clinic., Fukushima
RECRUITING
Hiroshima University Hospital, Hiroshima
RECRUITING
NHO Kure Medical Center and Chugoku Cancer Center, Hiroshima
RECRUITING
Asahikawa Medical University Hospital, Hokkaido
RECRUITING
Itami City Hospital, Hyōgo
RECRUITING
JA-Ibaraki Tsuchiura Kyodo General Hospital, Ibaraki
RECRUITING
University of Tsukuba Hospital, Ibaraki
RECRUITING
Kagoshima University Hospital, Kagoshima
RECRUITING
Tanaka Neurosurgical Clinic, Kagoshima
RECRUITING
St. Marianna University School of Medicine Hospital, Kanagawa
RECRUITING
Yokohama City University Hospital, Kanagawa
RECRUITING
Kumamoto Ezuko Rehabilitation Medical Center, Kumamoto
RECRUITING
NHO Nagasaki Medical Center, Nagasaki
RECRUITING
Koide Clinic of Epilepsy and Neurological Disorders, Osaka
RECRUITING
Osaka University Hospital, Osaka
RECRUITING
Shintokukai Nii Neurosurgery and Psychiatry Clinic, Osaka
RECRUITING
Ochiai Brain Clinic, Saitama
RECRUITING
TMG ASAKA Medical Center, Saitama
RECRUITING
Sakurai Clinic, Shiga
RECRUITING
NHO Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka
RECRUITING
Seirei Hamamatsu General Hospital, Shizuoka
RECRUITING
Seirei Mikatahara General Hospital, Shizuoka
RECRUITING
Jichi Medical University Hospital, Tochigi
RECRUITING
Tokushima University Hospital, Tokushima
RECRUITING
Medical Hospital, Tokyo Medical and Dental University, Tokyo
RECRUITING
National Center of Neurology and Psychiatry, Tokyo
RECRUITING
Tokyo Medical University Hospital, Tokyo
RECRUITING
NHO Yamagata National Hospital, Yamagata
Lead Sponsor
Ono Pharmaceutical Co. Ltd
INDUSTRY